A generic version of ibrutinib was granted tentative approval by the FDA for use in CLL and SLL with 17p deletion and Waldenström macroglobulinemia.

This latest approval builds on an earlier liquid formulation of generic methimazole for feline hyperthyroidism, which received FDA clearance earlier this month ...